Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Adverse Events in Treatment of Inherited Factor VII Deficiency: Final Analysis of the STER.

Guglielmo Mariani, MD, Mariasanta Napolitano, MD, Alberto Dolce, PhD, Marie Bertrand, MD, Pimlak Charoenkwan, MD, Dragan Micic, Maria Fernanda López Fernández, MD, Arlette Ruiz de Saez, Sergio Siragusa, MD, Jorgen Ingerslev

Blood (2012) 120 (21): 2279.

https://doi.org/10.1182/blood.V120.21.2279.2279

Published: 2012

Journal Articles

At Disease Presentation, Severity of the Bleeding Symptom Predicts the Following Bleeds in Patients with FVII Deficiency

Matteo ND Di Minno, Angelika Batorova, MD, PhD, Mariasanta Napolitano, MD, Alberto Dolce, PhD, Giovanni Di Minno, MD, Francesco Bernardi, PhD, Jean-Francois Schved, Jørgen Ingerslev, MD, Muriel Giansily-Blaizot, MD, PhD, Guenter K.H. Auerswald, Sr., MD, Guglielmo Mariani, MD

Blood (2011) 118 (21): 30.

https://doi.org/10.1182/blood.V118.21.30.30

Published: 2011

Journal Articles

Fibrinogen: A Procoagulant and An Anticoagulant

Catherine J Rea, MB, Benny Sorensen, MD, Ph.D, Jørgen Ingerslev, MD, Peter Laursen

Blood (2011) 118 (21): 384.

https://doi.org/10.1182/blood.V118.21.384.384

Published: 2011

Journal Articles

Pharmacokinetics of Factor VII

Massimo Morfini, Uriel Martinowitz, Angelika Batorova, MD, PhD, Alberto Dolce, PhD, Mariasanta Napolitano, MD, Jorgen Ingerslev, Jean-Francois Schved, Guglielmo Mariani, MD

Blood (2011) 118 (21): 2259.

https://doi.org/10.1182/blood.V118.21.2259.2259

Published: 2011

Journal Articles

Management of the Sponataneous Bleeding Episodes in Factor VII Deficiency. A Prospective Evaluation of the STER,

Blood (2011) 118 (21): 3368.

https://doi.org/10.1182/blood.V118.21.3368.3368

Published: 2011

Journal Articles

Coagulation Factor Activity Level and Clinical Bleeding Severity in Rare Bleeding Disorders: Results From the European Network of Rare Bleeding Disorders (EN-RBD),

Blood (2011) 118 (21): 3312.

https://doi.org/10.1182/blood.V118.21.3312.3312

Published: 2011

Journal Articles

Replacement Therapy for Minor Surgery and Invasive Procedures in Factor VII Deficiency: The STER Experience

Blood (2011) 118 (21): 1262.

https://doi.org/10.1182/blood.V118.21.1262.1262

Published: 2011

Journal Articles

Prophylaxis In Congenital Factor VII Deficiency, Indications, Efficacy and Safety: Results of the STER

Mariasanta Napolitano, MD, Muriel Giansily-Blaizot, MD, PhD, Alberto Dolce, PhD, Jens Bierre Knudsen, PhD, Jean-Francois Schved, MD, PhD, Guenter Auerswald, MD, Jorgen Ingerslev, MD, Tahir S Shamsi, MD, Carmen Altisent, MD, Pimlak Chararoenkwan, MD, Lisa Michaels, MD, Ampaiwan Chuansumrit, MD, Giovanni di Minno, MD, Umran Caliskan, MD, Guglielmo Mariani, MD

Blood (2010) 116 (21): 665.

https://doi.org/10.1182/blood.V116.21.665.665

Published: 2010

Journal Articles

Replacement Therapy for Surgery in FVII Deficiency: The Ster Experience Concerning 63 Interventions.

Guglielmo Mariani, MD, Angelika Batorova, MD, Alberto Dolce, PhD, Sergio Siragusa, MD, Mario Lapecorella, MD, Jens Bierre Knudsen, MD, Giovanni Di Minno, MD, Elvira Grandone, MD, Giuseppe Tagariello, MD, AnnaRita Tagliaferri, MD, Guenter K.H. K.H. Auerswald, Sr., MD, Jørgen Ingerslev, MD

Blood (2009) 114 (22): 1290.

https://doi.org/10.1182/blood.V114.22.1290.1290

Published: 2009

Journal Articles

Fibrinogen Concentrate Corrects Dilutional Coagulopathy: A Prospective, Randomized Placebo Controlled Clinical Trial.

Christian Fenger-Eriksen, MD, Tommy Midtgaard Jensen, Bo Kristensen, Klaus Møller Jensen, Else Tønnesen, Jørgen Ingerslev, MD, Benny Sorensen, M.D., Ph.D.

Blood (2008) 112 (11): 1227.

https://doi.org/10.1182/blood.V112.11.1227.1227

Published: 2008

Journal Articles

Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)

Blood (2008) 111 (10): 4979–4985.

https://doi.org/10.1182/blood-2007-09-110940

Published: 2008

Journal Articles

Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD

Blood (2008) 111 (7): 3531–3539.

https://doi.org/10.1182/blood-2007-08-109231

Published: 2008

Includes: Supplemental data

Journal Articles

Thrombelastographic Whole Blood Coagulation Parameters Demonstrate Improved Clot Strength Induced by Tranexamic Acid during Cardiopulmonary Bypass.

Benny Sørensen, MD, PhD, Thomas D. Christensen, MD, PhD, Mogens Harrits Jepsen, MD, Lars Folkersen, MD, Inge Severinsen, MD, Vibeke E. Hjortdal, MD, PhD, DMSc, Jørgen Ingerslev, MD, DMSc

Blood (2007) 110 (11): 3195.

https://doi.org/10.1182/blood.V110.11.3195.3195

Published: 2007

Journal Articles

Citrate Anticoagulant Artificially Masks the Hemostatic Effect of Recombinant Factor VIIA in Dilutional Coagulopathy.

Christian Fenger-Eriksen, MD, Jørgen Ingerslev, MD, DMSc, Else Tønnesen, MD, DMSc, Benny Sørensen, MD, PhD

Blood (2007) 110 (11): 3160.

https://doi.org/10.1182/blood.V110.11.3160.3160

Published: 2007

Journal Articles

Tranexamic Acid Increases Clot Stability in Patients with Severe Hemophilia A.

Anne-Mette Hvas, MD, PhD, Hanne Thykjaer Sorensen, Lisbeth Norengaard Sorensen, Kirsten Christiansen, Jorgen Ingerslev, MD, DMSc, Benny Sorensen, MD, PhD

Blood (2006) 108 (11): 1023.

https://doi.org/10.1182/blood.V108.11.1023.1023

Published: 2006

Journal Articles

Recombinant Factor VIIa Combined with Plasma Factor XIII Stabilize Clot Formation and Increase Clot Stability in Whole Blood from Patients with Severe Hemophilia A.

Benny Sorensen, MD, PhD, Rasmus Rojkjaer, Ph.D., Jorgen Ingerslev, MD, DMSC

Blood (2006) 108 (11): 1039.

https://doi.org/10.1182/blood.V108.11.1039.1039

Published: 2006

Journal Articles

Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)

Blood (2006) 109 (1): 112–121.

https://doi.org/10.1182/blood-2006-05-020784

Published: 2006

Includes: Supplemental data

Journal Articles

Inhibitor Haemophilia A - Cases with Reduced Haemostatic Response to Wildtype rFVIIa Who Achieved a Normal Clotting Profile with a Novel Potent Analogue of rFVIIa.

Benny Sørensen, MD, PhD, Egon Persson, PhD, Jørgen Ingerslev, MD DMSc.

Blood (2005) 106 (11): 3215.

https://doi.org/10.1182/blood.V106.11.3215.3215

Published: 2005

Journal Articles

What the Standard APTT Didn’t Tell You - Dynamic Plasma Clotting Parameters Reveal Hypercoagulation.

Benny Sørensen, MD, PdD, Peter Johansen, PhD, Kirsten Christiansen, Lisbeth Norengaard, Ole H. Larsen, Jørgen Ingerslev, MD, MDSc

Blood (2005) 106 (11): 2634.

https://doi.org/10.1182/blood.V106.11.2634.2634

Published: 2005

Journal Articles

Incidence and Outcome of Discontinuation of Prophylactic Treatment among Young Adults with Severe Hemophilia.

Karin van Dijk, MD, Kathelijn Fischer, MD, PhD, Johanna G. van der Bom, MD, PhD, Elma Scheibel, MD, PhD, Jørgen Ingerslev, MD, PhD, H. Marijke van den Berg, MD, PhD

Blood (2004) 104 (11): 3086.

https://doi.org/10.1182/blood.V104.11.3086.3086

Published: 2004

NARROW

Adverse Events in Treatment of Inherited Factor VII Deficiency: Final Analysis of the STER.

At Disease Presentation, Severity of the Bleeding Symptom Predicts the Following Bleeds in Patients with FVII Deficiency

Fibrinogen: A Procoagulant and An Anticoagulant

Pharmacokinetics of Factor VII

Management of the Sponataneous Bleeding Episodes in Factor VII Deficiency. A Prospective Evaluation of the STER,

Coagulation Factor Activity Level and Clinical Bleeding Severity in Rare Bleeding Disorders: Results From the European Network of Rare Bleeding Disorders (EN-RBD),

Replacement Therapy for Minor Surgery and Invasive Procedures in Factor VII Deficiency: The STER Experience

Prophylaxis In Congenital Factor VII Deficiency, Indications, Efficacy and Safety: Results of the STER

Replacement Therapy for Surgery in FVII Deficiency: The Ster Experience Concerning 63 Interventions.

Fibrinogen Concentrate Corrects Dilutional Coagulopathy: A Prospective, Randomized Placebo Controlled Clinical Trial.

Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)

Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD

Thrombelastographic Whole Blood Coagulation Parameters Demonstrate Improved Clot Strength Induced by Tranexamic Acid during Cardiopulmonary Bypass.

Citrate Anticoagulant Artificially Masks the Hemostatic Effect of Recombinant Factor VIIA in Dilutional Coagulopathy.

Tranexamic Acid Increases Clot Stability in Patients with Severe Hemophilia A.

Recombinant Factor VIIa Combined with Plasma Factor XIII Stabilize Clot Formation and Increase Clot Stability in Whole Blood from Patients with Severe Hemophilia A.

Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)

Inhibitor Haemophilia A - Cases with Reduced Haemostatic Response to Wildtype rFVIIa Who Achieved a Normal Clotting Profile with a Novel Potent Analogue of rFVIIa.

What the Standard APTT Didn’t Tell You - Dynamic Plasma Clotting Parameters Reveal Hypercoagulation.

Incidence and Outcome of Discontinuation of Prophylactic Treatment among Young Adults with Severe Hemophilia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only